المؤلفون: Gonzalez-Martin, A, Desauw, C, Heitz, F, Cropet, C, Gargiulo, P, Berger, R, Ochi, H, Vergote, I, Colombo, N, Mirza, M, Tazi, Y, Canzler, U, Zamagni, C, Guerra-Alia, E, Levache, C, Marme, F, Bazan, F, de Gregorio, N, Dohollou, N, Fasching, P, Scambia, G, Rubio-Perez, M, Milenkova, T, Costan, C, Pautier, P, Ray-Coquard, I, Gonzalez-Martin A., Desauw C., Heitz F., Cropet C., Gargiulo P., Berger R., Ochi H., Vergote I., Colombo N., Mirza M. R., Tazi Y., Canzler U., Zamagni C., Guerra-Alia E. M., Levache C. B., Marme F., Bazan F., de Gregorio N., Dohollou N., Fasching P. A., Scambia G., Rubio-Perez M. J., Milenkova T., Costan C., Pautier P., Ray-Coquard I.

مصطلحات الفهرس: Antiangiogenic agent, Bevacizumab, Olaparib, Ovarian cancer, PARP inhibitor, Second progression-free survival, info:eu-repo/semantics/article

URL: https://hdl.handle.net/10281/403081
info:eu-repo/semantics/altIdentifier/pmid/36067615
info:eu-repo/semantics/altIdentifier/wos/WOS:000858608000005
volume:174
firstpage:221
lastpage:231
numberofpages:11
journal:EUROPEAN JOURNAL OF CANCER

المؤلفون: Poveda, A, Floquet, A, Ledermann, J, Asher, R, Penson, R, Oza, A, Korach, J, Huzarski, T, Pignata, S, Friedlander, M, Baldoni, A, Park-Simon, T, Tamura, K, Sonke, G, Lisyanskaya, A, Kim, J, Filho, E, Milenkova, T, Lowe, E, Rowe, P, Vergote, I, Pujade-Lauraine, E, Byrski, T, Pautier, P, Harter, P, Colombo, N, Scambia, G, Nicoletto, M, Nussey, F, Clamp, A, Poveda Velasco, A, Rodrigues, M, Lotz, J, Selle, F, Ray-Coquard, I, Provencher, D, Prat Aparicio, A, Vidal Boixader, L, Scott, C, Yunokawa, M, Medioni, J, Pecuchet, N, Dubot, C, De La Motte Rouge, T, Kaminsky, M, Weber, B, Lortholary, A, Parkinson, C, Williams, S, Banerjee, S, Cosin, J, Hoffman, J, Plante, M, Covens, A, Joly, F, Hirte, H, Amit, A, Matsumoto, K, Tjulandin, S, Hoon Kim, J, Gladieff, L, Sabbatini, R, O'Malley, D, Timmins, P, Kredentser, D, Lainez Milagro, N, Barretina Ginesta, M, Tibau Martorell, A, Gomez De Liano Lista, A, Ojeda Gonzalez, B, Mileshkin, L, Mandai, M, Boere, I, Ottevanger, P, Nam, J, Hamizi, S, Cognetti, F, Warshal, D, Dickson-Michelson, E, Kamelle, S, Mckenzie, N, Rodriguez, G, Armstrong, D, Chalas, E, Celano, P, Behbakht, K, Davidson, S, Welch, S, Helpman, L, Fishman, A, Bruchim, I, Sikorska, M, Slowinska, A, Rogowski, W, Bidzinski, M, Spiewankiewicz, B, Casado Herraez, A, Mendiola Fernandez, C, Gropp-Meier, M, Saito, T, Takehara, K, Enomoto, T, Watari, H, Choi, C, Kim, B, Weon Kim, J, Hegg, R, Poveda A., Floquet A., Ledermann J. A., Asher R., Penson R. T., Oza A. M., Korach J., Huzarski T., Pignata S., Friedlander M., Baldoni A., Park-Simon T. -W., Tamura K., Sonke G. S., Lisyanskaya A., Kim J. -H., Filho E. A., Milenkova T., Lowe E. S., Rowe P., Vergote I., Pujade-Lauraine E., Byrski T., Pautier P., Harter P., Colombo N., Scambia G., Nicoletto M., Nussey F., Clamp A., Penson R., Poveda Velasco A., Rodrigues M., Lotz J. -P., Selle F., Ray-Coquard I., Provencher D., Prat Aparicio A., Vidal Boixader L., Scott C., Yunokawa M., Medioni J., Pecuchet N., Dubot C., De La Motte Rouge T., Kaminsky M. -C., Weber B., Lortholary A., Parkinson C., Ledermann J., Williams S., Banerjee S., Cosin J., Hoffman J., Plante M., Covens A., Sonke G., Joly F., Hirte H., Amit A., Matsumoto K., Tjulandin S., Hoon Kim J., Gladieff L., Sabbatini R., O'Malley D., Timmins P., Kredentser D., Lainez Milagro N., Barretina Ginesta M. P., Tibau Martorell A., Gomez De Liano Lista A., Ojeda Gonzalez B., Mileshkin L., Mandai M., Boere I., Ottevanger P., Nam J. -H., Filho E., Hamizi S., Cognetti F., Warshal D., Dickson-Michelson E., Kamelle S., McKenzie N., Rodriguez G., Armstrong D., Chalas E., Celano P., Behbakht K., Davidson S., Welch S., Helpman L., Fishman A., Bruchim I., Sikorska M., Slowinska A., Rogowski W., Bidzinski M., Spiewankiewicz B., Casado Herraez A., Mendiola Fernandez C., Gropp-Meier M., Saito T., Takehara K., Enomoto T., Watari H., Choi C. H., Kim B. -G., Weon Kim J., Hegg R.

مصطلحات الفهرس: Double-Blind Method, Female, Human, Middle Aged, Mutation, Neoplasm Recurrence, Local, Ovarian Neoplasm, Phthalazine, Piperazine, Genes, BRCA1, Genes, BRCA2, Tablets, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10281/327606
info:eu-repo/semantics/altIdentifier/pmid/33743851
info:eu-repo/semantics/altIdentifier/wos/WOS:000686283200030
volume:22
issue:5
firstpage:620
lastpage:631
numberofpages:12
journal:THE LANCET ONCOLOGY

المؤلفون: Alecu I, Milenkova T, Turner SR

المصدر: Drug Design, Development and Therapy, Vol Volume 12, Pp 347-348 (2018)

مصطلحات موضوعية: hematologic toxicities, PARP inhibitors, olaparib, neutropenia, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/let-risk-of-severe-hematologic-toxicities-in-cancer-patients-treated-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881

URL الوصول: https://doaj.org/article/065872888bd341ef899ea479ad56d585

المؤلفون: de Boer, R. ^*, Humblet, Y., Wolf, J., Nogová, L., Ruffert, K., Milenkova, T., Smith, R., Godwood, A., Vansteenkiste, J.

المصدر: In Annals of Oncology March 2009 20(3):486-491

المؤلفون: Poveda, A., Floquet, A., Ledermann, J.A., Asher, R., Penson, R.T., Oza, A.M., Korach, J., Huzarski, T., Pignata, S., Friedlander, M., Baldoni, A., Park-Simon, T.W., Tamura, K., Sonke, G.S., Lisyanskaya, A., Kim, J.H., Filho, E.A., Milenkova, T., Lowe, E.S., Rowe, P., Ottevanger, P.B., Vergote, I., Pujade-Lauraine, E.

المصدر: Lancet Oncology; 620; 631; 1470-2045; 5; 22; ~Lancet Oncology~620~631~~~1470-2045~5~22~~

المؤلفون: Penson, R. T., Valencia, R. V., Cibula, D., Colombo, N., Leath, C. A., Bidzinski, M., Kim, J. -W., Nam, J. H., Madry, R., Hernandez, C., Mora, P. A. R., Ryu, S. Y., Milenkova, T., Lowe, E. S., Barker, L., Scambia, Giovanni, Scambia G. (ORCID:0000-0003-2758-1063)

مصطلحات الفهرس: Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Middle Aged, Neoplasm Recurrence, Local, Ovarian Neoplasms, Phthalazines, Piperazines, Platinum Compounds, Genes, BRCA1, Genes, BRCA2, Germ-Line Mutation, Settore MED/40 - GINECOLOGIA E OSTETRICIA, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10807/206587
info:eu-repo/semantics/altIdentifier/pmid/32073956
info:eu-repo/semantics/altIdentifier/wos/WOS:000526811600007
volume:38
issue:11
firstpage:1164
lastpage:1174
numberofpages:11
issueyear:2020
journal:JOURNAL OF CLINICAL ONCOLOGY

المؤلفون: Penson, R, Valencia, R, Cibula, D, Colombo, N, Leath, C, Bidziński, M, Kim, J, Nam, J, Madry, R, Hernández, C, Mora, P, Ryu, S, Milenkova, T, Lowe, E, Barker, L, Scambia, G, Penson, Richard T, Valencia, Ricardo Villalobos, Cibula, David, Colombo, Nicoletta, Leath, Charles A, Bidziński, Mariusz, Kim, Jae-Weon, Nam, Joo Hyun, Madry, Radoslaw, Hernández, Carlos, Mora, Paulo A R, Ryu, Sang Young, Milenkova, Tsveta, Lowe, Elizabeth S, Barker, Laura, Scambia, Giovanni

مصطلحات الفهرس: olaparib, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10281/262650
info:eu-repo/semantics/altIdentifier/pmid/32073956
info:eu-repo/semantics/altIdentifier/wos/WOS:000526811600007
volume:38
issue:11
firstpage:1164
lastpage:1174
journal:JOURNAL OF CLINICAL ONCOLOGY

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Gourley, C., Brown, J.S., Lai, Z., Lao-Sirieix, P., Elks, C.E., McGarvey, H., French, T., Milenkova, T., Bloomfield, R., Rowe, P., Hodgson, D., Barrett, J.C., Moore, K., DiSilvestro, P., Harrington, E.A.

المصدر: In Annals of Oncology October 2019 30 Supplement 5:v407-v407